《全日總結》恆指跌112點 航運股受捧 藥明生物彈逾6%
滴滴出行母公司美股及其他在美上市中資科技股股價受壓，港股今日向下。恆指低開295點，早市曾跌369點一度低見27,703點，其後跌幅曾收窄至103點見27,969點，全日跌112點或0.4%，收27,960點；國指跌119點或1.2%，收10,149點；恆生科技指數跌43點或0.6%，收7,603點。大市全日成交總額1,565.6億元，滬、深港通南下交易淨流入金額分別爲5.81億及29.72億元人民幣。
科技股方面，阿裏巴巴(09988.HK)跌1.7%報205.8元，騰訊(00700.HK)跌1.9%報548.5元，美團(03690.HK)跌1.3%報286元，小米(01810.HK)跌0.8%報25.7元，京東(09618.HK)及百度(09888.HK)各跌2.1%及2.2%，嗶哩嗶哩(09626.HK)跌5%。快手(01024.HK)跌3.4%。
此外，汽車之家(02518.HK)跌2.1%，金蝶(00268.HK)及微盟(02013.HK)各跌2.8%及3.1%。恆騰(00136.HK)、明源雲(00909.HK)及心動(02400.HK)各升2.8%至3.3%。手機相關股信利(00732.HK)升6%，丘鈦(01478.HK)及舜宇(02382.HK)各升2.5%及3.6%，鴻騰(06088.HK)則跌6.8%。電訊設備股中興(00763.HK)及京信通訊(02342.HK)各跌2.6%及2.1%。
港交所(00388.HK)公佈落實簡化及數碼化港股首次公開招股程序，最快明年第四季落實，刺激股價升5.3%報491元。匯控(00005.HK)跌1.4%報44.6元。
體育用品股361度(01361.HK)及李寧(02331.HK)各升5.9%及5%，特步(01368.HK)升9%，安踏(02020.HK)升2.8%。汽車股吉利(00175.HK)半年銷售僅達目標41%，股價跌0.8%。廣汽(02238.HK)升10.9%，恆大汽車(00708.HK)及長城汽車(02333.HK)各升4.7%及2.9%。鋰電池材料商贛鋒鋰業(01772.HK)升6.6%。醫樂股藥明生物(02269.HK)升6.4%。石藥(01093.HK)升4.7%。藥明康德(02359.HK)及白雲山(00874.HK)各升7.1%及4.2%，綠葉製藥(02186.HK)則跌2.9%。
環保能源股再受捧，龍源(00916.HK)及金風科技(02208.HK)各升3.3%及2.7%，信義光能(00968.HK)升5.5%。福萊特玻璃(06865.HK)炒高12.3%。航運股亦上漲，中遠海控(01919.HK)升9.8%，東方海外(00316.HK)及太平洋航運(02343.HK)各升4.3%及4.8%。金屬股洛鉬(03993.HK)升9.3%，鋼鐵股馬鋼(00323.HK)及鞍鋼(00347.HK)各升4%及4.8%。
新股方面，小鵬汽車(09868.HK)收報165元，與上市價持平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
